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ABSTRACT
Objective: This study aims to explore the knowledge, experience, and
attitudes toward economic evaluation (EE) among decision-makers and
researchers in Thailand.
Methods: Researchers were purposively selected from Thai academics and
both public and private research organizations related to EE. Decision-
makers at the provincial level were purposively selected from the members
of the Management Committees of Provincial Health Ofﬁces, and those at
hospital level were randomly selected from members of the public and
private hospital formulary drug committees throughout Thailand. The
self-administered postal questionnaires were distributed. Univariate and
bivariate analyses were applied.
Results: Of the total 2575 questionnaires distributed, 758 (29.4%
response rate) were completed and sent back. The majority of researchers
and decision-makers were not familiar with technical terms commonly
used in health EE, e.g., incremental cost-effectiveness ratio, discounting,
and sensitivity analysis. More decision-makers (70.6%) had never had EE
training compared to researchers (50.0%). Both roles indicated that value
for money was one of the important issues to consider for health technol-
ogy adoption.
Conclusions: An extensive unmet demand for EE training among Thai
researchers and decision-makers still exists. Findings from this study con-
tribute to the short- and long-term plans for research capacity building.
Keywords: capacity, economic evaluation, pharmacoeconomics, survey,
Thailand.
Introduction
Because of the growing health needs of an aging population and
the advancement in health technology, especially pharmaceuti-
cals, health-care costs have been rapidly increasing in the Thai
health-care system. Rising health expenditure has caused con-
cerns among policymakers and practitioners to make the most
efﬁcient use of scarce health-care resources. As a consequence,
economic evaluation (EE) or pharmacoeconomic assessment
deﬁned as a “policy research” that identiﬁes, measures, and
compares the costs and consequences of medical technology [1]
was introduced to guide health-care resource allocation decisions
[2,3]. Recently, the ﬁrst national guidelines for conducting EE
were endorsed in March 2008 by the subcommittee for the
development of the National List of Essential Drugs (NLED),
which is the only pharmaceutical reimbursement list in Thailand,
and referred to by all major public health planners. In addition,
the revision of the 2008 NLED included pharmacoeconomic
evidence which was ofﬁcially incorporated in the drug selection
process for the ﬁrst time in Thai history [4].
Because EE is a relatively new discipline in Thailand, there
was wider concern over the feasibility of using EE for decision-
making, especially at the local or hospital level [5]. Teerawat-
tananon et al. extensively documented the potential and barriers
of using EE for informing health-care coverage decisions at the
national level; however, there was no study examining these
challenges at the subnational level [6]. Ross proposed that the use
of EE by decision-makers is inﬂuenced by three main factors [7].
The ﬁrst is that the users have knowledge of the method, the
second is whether they perceive any overall beneﬁt in using it,
and the third is if they perceive the relative importance of mar-
ginal efﬁciency compared with other objectives as a factor
inﬂuencing resource allocation decisions in their particular
health-care system. In addition, it is also recognized that the
potential constraints to the use of EE come from not only about
the lack of understanding and support among the potential users
but also the barriers related to the production of EE information.
Expanding local research capacity is essential because decision-
makers prefer to use locally relevant information over interna-
tional data.
This present study aims to explore decision-makers’ knowl-
edge, experience, and attitudes toward the use of EE at the
subnational level as well as to assess the current human capacity
and gaps in EE among those decision-makers and Thai scholars.
This study focused on two groups of decision-makers. The ﬁrst
are the members of the Management Committee (MC) of each
Provincial Health Ofﬁce (PHO), who are responsible for capital
investment at health centers, community hospitals, and provin-
cial hospitals, supporting vertical public health programs and
human resource development at the provincial level. The MC
normally consists of heads and deputies of PHO, heads of PHO’s
departments, heads of District Health Ofﬁces, and directors
of community and provincial hospitals. The second are the
members of the Hospital Drug Formulary Committees (HDFCs),
who are responsible for the selection of drugs purchased and
used in each hospital. The HDFC includes heads of hospital
pharmacies and representatives from each group of physi-
cians, e.g., surgeons, pediatricians, internists, obstetricians, and
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ophthalmologists. Lastly, scholars included university lecturers
and researchers at both public and private institutes who search
for or provide EE evidence and educate the public.
Because there is an increasing interest to use economic evi-
dence for resource allocation, a better understanding of the
decision-makers’ and scholars’ knowledge, attitude, and value
toward the use of EE will provide useful evidence that can be
employed for the development of human resources and relevant
health system infrastructure in both short- and long-term
periods. Lessons learned from this study can also be useful not
only for the Thai health-care system but also in other developing




Data were collected through a questionnaire survey conducted by
the authors between April and December 2007. The samples
consisted of members of the MC of all 75 PHOs and members of
the HDFC of 100 hospitals that were randomly selected from a
total of 1044 community, provincial, and regional hospitals
throughout Thailand. To our knowledge, the actual number of
researchers who had an expertise of health economics was
unknown. Nevertheless, the sample frame for researchers
included all potential contributors (i.e., faculty members and
researchers in both public and private organizations). Both
research-only staffs as well as lecturers who were expected to
have EE expertise from 29 academic institutions, particularly in
the Department of Community and Family Medicine at the
Faculty of Medicine, Department of Social and Administrative
Pharmacy at the Faculty of Pharmacy, the Faculty of Public
Health, and the Faculty of Economics throughout Thailand, were
purposively selected. Moreover, the researchers from 16 relevant
research units in the government sector as well as pharmaceutical
companies were included because until now no private EE con-
sulting company has established in Thailand yet. Because the
survey mainly focused on the knowledge, experience, and atti-
tudes of Thai researchers and decision-makers with regard to EE,
the survey sample excluded academics and consultants working
in countries other than Thailand. They did, however, have the
potential to produce EE information related to Thai context.
Table 1 shows the number of questionnaires sent by type of
organizations. For Table 1, see The Current Capacity and Future
Development of Economic Evaluation for Policy Decision
Making: A Survey among Researchers and Decision Makers




Self-administered postal questionnaires were sent to the afore-
mentioned samples. The questionnaire consisted of four parts.
The ﬁrst part focused on the sociodemographic characteristics of
survey respondents and their current organizational roles. The
second part contained eight questions relating to respondents’
knowledge and experience of EE and their attitudes toward the
use of EE in making health resource allocation decisions. For
example, how important is the criteria of “value for money”
when making decisions concerning health-care resource alloca-
tion, or how useful is EE information when developing national
drug formulary? The third part concentrated on the potential
barriers in conducting EE studies or applying EE into practice or
policy decision. The respondents were requested to rate on the
prespeciﬁed attributes of the criteria for resource allocation the
usefulness of EE information and potential barriers. In addition,
given the information on the list of diseases without stating the
rank of disease burden in terms of Disability Adjusted Life Years
(DALYs) loss among the Thai population, the last part was to
request the respondents to prioritize the top ﬁve health problems
where EE could play a signiﬁcant role in identifying interventions
to mitigate their impact. After the respondents prioritized the top
ﬁve diseases and interventions based on the list of disease burden
in Thailand and interventions, a scale from 1 to 5 where 5
corresponded to “the ﬁrst rank” and 1 to “the ﬁfth rank” was
assigned to calculate the mean score.
Because of the variations in the number of members in the
MC and the HDFC, the number of postal questionnaires was
based on hospital types, e.g., community or private (5 copies),
regional (10 copies), and specialist or general (20 copies). With
respect to researchers, the postal questionnaires were personally
addressed to each potential researcher and sent to each of the 29
academic institutions and 16 public and private sector research
units. The questionnaire was prestamped and the return address
was printed on the back of the envelope to facilitate the return of
the completed questionnaire. A total of 2575 questionnaires with
a letter explaining the purpose of the study were mailed in April
2007. Approximately 1 month after mailing, telephone calls were
made to questionnaire respondents to verify whether they had
received the questionnaires and to stimulate nonrespondents.
Data Analysis
Data were analyzed comparing knowledge, experience, attitudes,
and the value of using EE to inform the decision-making process
of the two groups of respondents, i.e., decision-makers at the
subnational level and researchers. Univariate and bivariate sta-
tistical analyses were applied. The statistical differences of ﬁnd-
ings between the two groups were detected using a t test or a
chi-square test where appropriate.
Results
Response Rate and Demographic Characteristics
of Respondents
Of the total 2575 questionnaires distributed, 758 (29.4%
response rate) were completed and sent back. Table 1 shows the
response rate by type of respondents. The highest response rate
was obtained from researchers in the public sector followed by
researchers from the private sector and hospital formulary com-
mittee members. It was noted that faculty members at the aca-
demic institutions provided the lowest response rate. Researchers
had a higher proportion of completing master (68% vs. 34%)
and doctoral degrees (23% vs. 5%) compared to decision-
makers. For Table 1, see The Current Capacity and Future Devel-
opment of Economic Evaluation for Policy Decision Making: A
Survey among Researchers and Decision Makers in Thailand
Value in Health Supplementary Information, Part I at: http://
www.ispor.org/Publications/value/ViHsupplementary/ViH12s3_
Chaikledkaew.asp.
Knowledge, Experience and Training Needs Related
to EE
The survey showed limited knowledge and experience in the
production and use of EE information among respondents.
Figure 1 illustrates that the majority of researchers and decision-
makers were not familiar with technical terms commonly used in
health EE, e.g., incremental cost-effectiveness ratio (ICER), dis-
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counting, and sensitivity analysis. Nevertheless, they were more
familiar with the general terms used in costing studies (i.e., unit
cost, direct and indirect costs). This may be partly explained by
the fact that 50% of researchers and 71% of decision-makers
had not been trained in EE. For those trained in EE, short-course
training and taught courses in master’s or doctoral studies were
among the major sources of services provided for both groups. In
addition, it was found that 20% of researchers and only 7% of
decision-makers had ever been involved in conducting EE
studies, and only a few of them (10% for researchers and 4% for
decision-makers) have previously published EE papers in domes-
tic or international academic journals. Table 2 demonstrates the
need of EE training by type of respondents. More than 80% of
both researchers and decision-makers showed their interests in
short-course training and on-the-job training, respectively.
Decision-makers were signiﬁcantly more interested in short-
course EE training and master’s study, whereas researchers pre-
ferred to take part in long-term research fellowship programs
related to EE in health care. For Figure 1 and Table 2, see The
Current Capacity and Future Development of Economic Evalu-
ation for Policy Decision Making: A Survey among Researchers
and Decision Makers in Thailand Value in Health Supplementary
Information, Part II at: http://www.ispor.org/Publications/value/
ViHsupplementary/ViH12s3_Chaikledkaew.asp.
Relative Importance and Usefulness of EE Information
in Policy Decision-Making
Both researchers and decision-makers similarly indicated that
safety, efﬁcacy/effectiveness, quality of life, value for money, and
disease severity were more important issues to be considered
when they needed to make policy decisions regarding the intro-
duction of new health technology compared with political pres-
sure, the availability of alternatives, and the price of technology
(Fig. 2). Furthermore, the majority of researchers and decision-
makers shared a common agreement that EE information was
useful for the development of national drug formulary, followed
by the development of hospital drug formulary, clinical practice
guidelines, and communicating with prescribers (Fig. 3). For
Figures 2 and 3, see The Current Capacity and Future Develop-
ment of Economic Evaluation for Policy Decision Making: A
Survey among Researchers and Decision Makers in Thailand
Value in Health Supplementary Information, Part II at: http://
www.ispor.org/Publications/value/ViHsupplementary/ViH12s3_
Chaikledkaew.asp.
Barriers for the Production and Use of EE in Policy and
Practice in Thailand
Researchers indicated that the main barriers related to the pro-
duction of economic evidence for assisting policy decisions in
Thailand included a lack of EE methodological skills among
researchers, inadequate human resources, lack of local informa-
tion regarding the costs and effectiveness of interventions, no clear
government policy regarding the use of EE in policy decisions,
inadequate ﬁnancial support from grantors, lack of time, and lack
of support from their own organizations (Fig. 4). Regarding the
use of EE in policy decisions, decision-makers revealed that the
main obstacles were the lack of an explicit ceiling threshold that
the society is willing to pay for a quality adjusted life year (QALY)
orDALYgained followed by the lack of EE studies/information on
particular topics that are of interest to decision-makers, awareness
of a potential bias of the study because of industry sponsorship, a
lack of conﬁdence in interpreting and using EE results, no clear
government policy on the use of EE, disagreement with efﬁciency
criteria for health-care resource allocation, and political barriers
(Fig. 5). For Figures 4 and 5, see The Current Capacity and Future
Development of Economic Evaluation for Policy Decision
Making: A Survey among Researchers and Decision Makers in
Thailand Value in Health Supplementary Information, Part IV at:
http://www.ispor.org/Publications/value/ViHsupplementary/
ViH12s3_Chaikledkaew.asp.
Prioritization of Diseases and Interventions for
Conducting EE in Thailand
Regarding the ranking scores of diseases and interventions, the
respondentswere given the list of diseaseswithout being presented
the rank of disease burden in terms of DALY loss among the Thai
population. They were given this before they were asked to
prioritize the top ﬁve diseases and interventions where EE should
be used to produce cost-effectiveness information. Table 3 shows
the list of 14 leading causes of diseases burden and the ranks of
topics for economic assessment assigned by researchers and
decision-makers in Thailand. It can be seen that both groups of
respondents commonly agree that EE studies should focus on
HIV/AIDS, trafﬁc accident, diabetes, and homicide. These were
also the top four health problems in terms of DALY loss in
Thailand. Apart from that, there was no common agreement on
the topics for economic assessment between disease burden and
respondents’ perception. For Table 3, see The Current Capacity
and Future Development of Economic Evaluation for Policy Deci-
sion Making: A Survey among Researchers and Decision Makers
in Thailand Value in Health Supplementary Information, Part V
at: http://www.ispor.org/Publications/value/ViHsupplementary/
ViH12s3_Chaikledkaew.asp.
Moreover, regarding the type of interventions for performing
EE, both researchers and decision-makers similarly prioritized
that the ﬁrst, third, and ﬁfth ranks were prevention, screening for
secondary prevention, and curative by surgery, respectively. Nev-
ertheless, at the second rank, decision-makers considered social/
community intervention, whereas researchers selected screening
for secondary prevention, which decision-makers ranked fourth
(Table 3). More than 50% of researchers (58.6%) and decision-
makers (51.8%) revealed that they ranked in this fashion because
those diseases were a health-care burden in Thailand. Further-
more, they had personal interests in those diseases and interven-
tions and noticed that the cost-ineffective interventions in those
diseases or interventions tended to be overused, whereas the
cost-effective interventions seemed to be underused.
Discussion
This present study is the ﬁrst to investigate the capacity, attitude,
and perception of both researchers and decision-makers concern-
ing the use of EE for policy decision-making as well as the
prioritization criteria used for selecting topics for economic
assessment in developing settings. Nevertheless, the survey
results may not represent what all decision-makers and research-
ers in Thailand thought about EE because of a relatively low
response rate that would be expected from this type of survey.
Given that the actual number of respondents who had an exper-
tise of EE in each setting was unknown, the number of question-
naires sent to individuals within the sample frame was assumed
and seemingly estimated higher than the actual number of
respondents to cover all research staffs and decision-makers at
the selected departments and organizations. Consequently, the
response rate calculated by the proportion of the number of
returned questionnaires and the number of sent questionnaires is
likely to be underestimated. In addition, it is possible that
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decision-makers and researchers who lack EE knowledge and
who are interested in EE training responded to the survey, unlike
those who are familiar with EE knowledge. Although the respon-
dents may not be representative of the sample frame, the number
of respondents who returned the questionnaires seemed adequate
to make sensible policy recommendations for improving the use
of EE in decision-making in Thailand.
Based on the survey results, both researchers and decision-
makers had very positive attitudes toward the use of EE. In
addition to safety, efﬁcacy/effectiveness, and quality of life, cost-
effectiveness information resulting from EEwas considered as one
of the important criteria for making decisions concerning health
technology adoption in Thailand and was deemed useful for the
development of the national drug formulary. Although both
groups of respondents recognized the usefulness of EE, only
one-third had ever used EE information in their current work.
These ﬁndings were similar to the results obtained from the
European Network on Methodology and Application of Eco-
nomic Evaluation Techniques’s study, which demonstrated that
although two-thirds of decision-makers from nine European
countries (i.e., Finland, France, Germany, Norway, Portugal,
Spain, Sweden, The Netherlands, and the UK) appreciated the
usefulness of EE information, only a third of them had ever really
used it in real practice [8]. These results also concurred with the
previous studies in the UK [9–11]. It was concluded that an
increase in the use of EE was because of the reforms of the
National Health Service in the UK. Nevertheless, decision-makers
still needed help in interpreting the methodology and results of EE
as well as in increasing their knowledge and understanding of EE.
Moreover, this study revealed a number of potential barriers
to the production of EE from a researchers’ viewpoint as well as
the potential barriers related to the use of EE by decision-makers.
These barriers related to the production of EE information
include a lack of knowledge and skills, an inadequate number of
research staff, a lack of local information, and a lack of incentives
and support for conducting EE studies. Decision-makers revealed
that a lack of EE information, the potential bias of EE studies
because of industry sponsorship, and a lack of knowledge and
skills to interpret EE information were among the major resis-
tance factors concerning the use of EE in policy decision-making.
Similarly, Drummond et al. suggested that the major obstacles
for decision-makers were the concerns over the validity of eco-
nomic studies, leading to a lack of conﬁdence in applying it into
policy and to the lack of knowledge and understanding in EE [9].
Even though decision-makers strongly indicated that the lack of
a ceiling threshold was the potential barrier diminishing the use
of EE information for policy decision-making in Thailand, it
seems very questionable whether respondents really understand
the concept of a ceiling threshold given that a majority of them
could not interpret the ICER term. It is possible that there may be
a bias toward neutral response categories when rating the poten-
tial barriers related to the use of EE information in policy
decision-making. Thus, interpreting and using these ﬁndings
needs to be done with caution.
Furthermore, the lack of EE knowledge among researchers
may lead to the lack of EE studies in Thailand, especially for
urgent policymaking. When looking at the publication experi-
ence of all respondents in this study, only 10% of researchers and
4% of decision-makers had ever published EE studies. Similar
results also found in Australia indicated that 47% of Australian
decision-makers agreed that there was no appropriate EE study
available when they had to make policy decisions in a short time
period [7]. Teerawattananon’s study showed that only 41 EE
publications related to the Thai health-care setting on Pubmed
databases during 1982 to 2005 were found, and among these
publications there was a lack of EE publications of 15 of the top
20 major health problems in Thailand because of the poor dis-
tribution of research funding in areas of major health problems
[6]. In this study, the respondents also prioritized the top ﬁve
diseases that needed to be conducted through EE studies (i.e.,
AIDS, diabetes, homicide, trafﬁc accident, and chronic obstruc-
tive pulmonary disease (COPD)/anemia) because those diseases
corresponded to the list of disease burden in Thailand. Interest-
ingly enough, both researchers and decision-makers agreed that
the ﬁrst rank of intervention needed to be performed through EE
was individual prevention. It is fascinating that both parties
realized the importance of EE information with regard to pre-
vention intervention instead of curative intervention by treat-
ment, the most common intervention usually conducted in EE
studies. Based on the viewpoint of researchers, the second rank
was curative intervention by treatment, whereas decision-makers
indicated that it was social/community intervention. Because
most decision-makers in this study are responsible for managing
health-care resource allocation at the provincial and hospital
levels, particularly in rural areas, they might comprehend the
signiﬁcance of social/community interventions to a greater extent
than researchers.
In addition, the lack of EE knowledge among researchers may
result in the lack of high-quality EE studies, which could limit the
application of these EE studies. Decision-makers might hesitate to
adopt the EE ﬁndings and use them for policy decision-making
because theymight have concerns regarding not only the quality of
EE studies but also the potential industry sponsorship bias of EE
studies. This was conﬁrmed by Teerawattananon et al.’s study,
which showed that serious attention needed to be given to the
quality of reporting and the use of information in the analyses [6].
Therefore, the lack of EE training may be a major explana-
tion for the knowledge gap in EE. Of all 58 respondents working
as researchers, only about 50% had never experienced any EE
training, whereas approximately 71% of respondents with the
role of decision-makers had never been trained in EE. Likewise,
most decision-makers in European counties (i.e., Finland, France,
Germany, Norway, Portugal, Spain, Sweden, The Netherlands,
and the UK) also had very limited knowledge of cost–beneﬁt
analysis, cost-effectiveness analysis, or cost–utility analysis, and
only one-third had attended health economics training [11,12].
Similar to decision-makers in Australia, 26% of them accepted
that they lacked EE knowledge and expertise in all areas as well
as EE training, and this represented a signiﬁcant barrier to the use
of EE [7]. It should be noted that the majority of researchers and
decision-makers showed their interest in short-course training,
on-the-job training, long-distance curriculum, and short-tem
research fellowships, respectively. Nevertheless, the responses do
not always reﬂect actual practice. It is difﬁcult to observe whether
those who stated that they used EE in decision-making or were
willing to take EE training have the chance or will do so in real
practice.
At the moment, partly as a consequence of this study, the
Health Intervention and Technology Assessment Program
(HITAP), a nonproﬁt organization ﬁnancially supported by
public organizations responsible for appraising health technolo-
gies and interventions in Thailand, has annually provided both
basic and advanced EE training to strengthen human capacity
toward EE for interested researchers and decision-makers from
both public and private organizations. This would help research-
ers and decision-makers improve their EE knowledge to over-
come the barrier to producing high-quality EE research as well
as to use EE information in policy decision-making. Ultimately,
EE training will help build human capacity toward EE and
strengthen EE of health care in Thailand in the future.
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Conclusions
Even though EE is perceived as essential information for health
policy decision-making, researchers and decision-makers still
lack EE knowledge and skills. Extensive unmet demand for EE
training that HITAP has been responsible to provide for Thai
researchers and decision-makers still exists. Findings from this
study contribute to the short- and long-term plans for research
capacity building and strengthening in EE of health care. Regular
monitoring of progress achieved in human, institutional research
capacity, and fundamental system related to EE is recommended.
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